Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,992
  • Shares Outstanding, K 116,356
  • Annual Sales, $ 9,990 K
  • Annual Income, $ -119,760 K
  • EBIT $ -92 M
  • EBITDA $ -90 M
  • 60-Month Beta 1.76
  • Price/Sales 13.39
  • Price/Cash Flow N/A
  • Price/Book 22.42

Options Overview Details

View History
  • Implied Volatility 171.52% ( +9.39%)
  • Historical Volatility 413.89%
  • IV Percentile 77%
  • IV Rank 47.13%
  • IV High 302.14% on 12/10/24
  • IV Low 55.08% on 06/24/24
  • Put/Call Vol Ratio 1.68
  • Today's Volume 7,627
  • Volume Avg (30-Day) 8,912
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 122,942
  • Open Int (30-Day) 100,921

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.21
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +45.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9500 +13.68%
on 12/18/24
10.4800 -89.69%
on 11/26/24
-7.5700 (-87.51%)
since 11/18/24
3-Month
0.9500 +13.68%
on 12/18/24
10.6237 -89.83%
on 11/11/24
-6.7700 (-86.24%)
since 09/18/24
52-Week
0.9500 +13.68%
on 12/18/24
10.6237 -89.83%
on 11/11/24
-1.8800 (-63.51%)
since 12/18/23

Most Recent Stories

More News
Stocks Set for Muted Open as Investors Await U.S. Jobs Data and Powell’s Remarks

December S&P 500 E-Mini futures (ESZ24) are down -0.12%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.19% this morning as investors looked ahead to remarks from Federal Reserve Chair Jerome...

DG : 75.94 (-0.08%)
FL : 22.07 (-0.85%)
NQZ24 : 21,183.00 (-3.78%)
STLAP.FP : 12.746 (-0.06%)
TSLA : 440.13 (-8.28%)
LRCX : 75.20 (-3.35%)
CHWY : 31.86 (-5.21%)
UPST : 73.32 (-11.65%)
ESZ24 : 5,872.75 (-2.99%)
DOCU : 92.71 (-5.56%)
KLAC : 630.77 (-3.68%)
ULTA : 416.60 (-1.65%)
Applied Therapeutics Stock Craters After FDA Rejects Rare Genetic Disorder Drug Candidate: Retail Mood Dented

A CRL is a communication from the FDA that the agency cannot approve a pending regulatory application before it in its present form.

IWO : 289.01 (-4.22%)
APLT : 1.0800 (-1.82%)
XBI : 89.93 (-4.93%)
Stock Index Futures Climb as Bond Yields Fall

December S&P 500 E-Mini futures (ESZ24) are up +0.31%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.38% this morning as Treasury yields fell after cash trading resumed following the Thanksgiving...

MSTR : 349.64 (-9.52%)
MARA : 21.61 (-12.15%)
CRWD : 349.18 (-7.24%)
RMBL : 5.03 (-10.66%)
AAL.LN : 2,415.000 (-0.62%)
NQZ24 : 21,183.00 (-3.78%)
HPQ : 32.49 (-3.99%)
APLT : 1.0800 (-1.82%)
URBN : 53.04 (-3.81%)
VNET : 3.58 (-9.14%)
BTBT : 3.71 (-12.09%)
ESZ24 : 5,872.75 (-2.99%)
Applied Therapeutics Receives Complete Response Letter from FDA for Govorestat New Drug Application for Classic Galactosemia

Applied Therapeutics received a Complete Response Letter from the FDA for govorestat's NDA for Classic Galactosemia.Quiver AI SummaryApplied Therapeutics, Inc. announced that the FDA has issued a Complete...

APLT : 1.0800 (-1.82%)
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

APLT : 1.0800 (-1.82%)
Applied Therapeutics Reports Third Quarter 2024 Financial Results

APLT : 1.0800 (-1.82%)
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

APLT : 1.0800 (-1.82%)
Why Applied Therapeutics Stock Is Skyrocketing Today

Investors are cheering good news from the FDA.

APLT : 1.0800 (-1.82%)
Stocks Set to Open Higher as Investors Await U.S. Jobs Data and Fed Speak

June S&P 500 E-Mini futures (ESM24) are up +0.10%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.14% this morning as investors digested the latest U.S. inflation figures and looked ahead to remarks...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
EL : 74.96 (-4.12%)
WBA : 9.70 (-2.71%)
RH : 396.39 (-3.72%)
MLKN : 24.33 (-3.80%)
CURV : 4.38 (-3.52%)
APLT : 1.0800 (-1.82%)
T : 22.48 (-1.53%)
CCJ : 51.93 (-2.79%)
DVN : 31.10 (-3.33%)
BILL : 83.69 (-4.31%)
S&P Futures Tick Lower as Key U.S. Jobs Report Looms

March S&P 500 E-Mini futures (ESH24) are trending down -0.23% this morning as investors looked ahead to the crucial monthly U.S. nonfarm payrolls report for further clues on the timing of possible interest-rate...

ESH24 : 5,101.67s (-1.01%)
WBA : 9.70 (-2.71%)
MBLY : 17.35 (-11.66%)
AAPL : 248.05 (-2.14%)
ALL : 189.25 (-2.15%)
EDV.LN : 1,439.000 (-0.55%)
LIGHT.NA : 21.300 (+0.47%)
PTON : 9.44 (-10.69%)
APLT : 1.0800 (-1.82%)
IBM : 220.17 (-3.84%)
FUSN : 21.55 (+0.14%)
PLTR : 71.51 (-3.87%)

Business Summary

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment...

See More

Key Turning Points

3rd Resistance Point 1.2163
2nd Resistance Point 1.1731
1st Resistance Point 1.1366
Last Price 1.0800
1st Support Level 1.0569
2nd Support Level 1.0137
3rd Support Level 0.9772

See More

52-Week High 10.6237
Fibonacci 61.8% 6.9283
Fibonacci 50% 5.7868
Fibonacci 38.2% 4.6454
Last Price 1.0800
52-Week Low 0.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar